Went Gregory T
Chief Executive Officer at Adamas Pharmaceuticals Inc
- Sold, on record
- $1M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Mar 20, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Adamas Pharmaceuticals IncChief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Adamas Pharmaceuticals IncPlan not statedMar 20 2015
Sold 300 shares at $18.00 ($5k)
Went Gregory T, Chief Executive Officer
Sold 2.9% of holdings ($186k position)10,008 shares leftFiling
- 2 Form 4 sale Adamas Pharmaceuticals IncUnusualApr 14 +25 days
Sold 4,757 shares at $18.25 ($87k)
Went Gregory T, Chief Executive Officer
Sold 32.2% of holdings ($270k position)10,008 shares leftFiling
- 3 Form 4 sale Adamas Pharmaceuticals IncUnusualApr 21 +7 days
Sold 10,583 shares at $18.00 ($191k)
Went Gregory T, Chief Executive Officer
Sold 34.6% of holdings ($551k position)20,008 shares left2.2x usual sizeFiling
- 4 Form 4 sale Adamas Pharmaceuticals IncPlan not statedApr 23 +2 days
Sold 3,300 shares at $18.01 ($59k)
Went Gregory T, Chief Executive Officer
Sold 14.2% of holdings ($420k position)20,008 shares left0.4x usual sizeFiling
- 5 Form 4 sale Adamas Pharmaceuticals IncPlan not statedMay 14 +21 days
Sold 2,728 shares at $18.00 ($49k)
Went Gregory T, Chief Executive Officer
Sold 8.3% of holdings ($589k position)30,008 shares left0.6x usual sizeFiling
- 6 Form 4 sale Adamas Pharmaceuticals IncPlan not statedMar 21 +677 days
Sold 2,807 shares at $17.03 ($48k)
Went Gregory T, Chief Executive Officer
Sold 1.7% of holdings ($2.9M position)166,526 shares left0.7x usual sizeFiling
- 7 Form 4 sale Adamas Pharmaceuticals IncPlan not statedMar 21 +365 days
Sold 4,541 shares at $25.75 ($117k)
Went Gregory T, Chief Executive Officer
Sold 2.4% of holdings ($4.8M position)182,610 shares leftFiling
- 8 Form 4 sale Adamas Pharmaceuticals IncPlan not statedMar 20 +364 days
Sold 6,319 shares at $7.99 ($50k)
Went Gregory T, Chief Executive Officer
Sold 3.5% of holdings ($1.5M position)176,291 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2019 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 6,319 | $50k | 3.5% | Plan not stated | SEC |
| Mar 21, 2018 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 4,541 | $117k | 2.4% | Plan not stated | SEC |
| Mar 21, 2017 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 2,807 | $48k | 1.7% | Plan not stated | SEC |
| May 14, 2015 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 2,728 | $49k | 8.3% | Plan not stated | SEC |
| Apr 23, 2015 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 3,300 | $59k | 14.2% | Plan not stated | SEC |
| Apr 21, 2015 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 10,583 | $191k | 34.6% | Unusual | SEC |
| Apr 14, 2015 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 4,757 | $87k | 32.2% | Unusual | SEC |
| Mar 20, 2015 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 300 | $5k | 2.9% | Plan not stated | SEC |
| Mar 19, 2015 | Adamas Pharmaceuticals Inc | Chief Executive Officer | Form 4 sale | 23,088 | $416k | 69.8% | Unusual | SEC |